Oxidative stress in a phenylketonuria animal model

被引:45
作者
Ercal, N
Aykin-Burns, N
Gurer-Orhan, H
McDonald, JD
机构
[1] Univ Missouri, Dept Chem, Rolla, MO 65409 USA
[2] Wichita State Univ, Dept Biol Sci, Wichita, KS 67208 USA
关键词
phenylketonuria; oxidative stress; glutathione; free radicals;
D O I
10.1016/S0891-5849(02)00781-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Oxidative stress is seen in various metabolic disorders for unknown reasons. Oxidative stress is defined as an imbalance between pro-oxidant and antioxidant status in favor of the former. This study investigated whether oxidative stress exists in phenylketonuria (PKU) using the BTBR-Pah(enu2) animal model for PKU. Animals (14-24 weeks old) were sacrificed and brain and red blood cells (RBCs) were obtained aseptically. The lipid peroxidation by-product, evaluated as malondialdehyde (MDA), was significantly higher in the brains and RBCs of PKU animals (n = 6) than in controls (n = 6). Glutathione/glutathione disulfide, a good indicator for tissue thiol status, was significantly decreased both in the brains and RBCs. Some antioxidant enzymes were also analyzed in RBCs, including glucose-6-phosphate dehydrogenase (G6PD), which provides the RBC's main reducing power, reduced nicotinamide adenine dinucleotide phosphate (NADPH), and catalase detoxifies H2O2 by catalyzing its reduction to O-2 and H2O. Both catalase and G6PD were significantly increased in the RBCs of PKU animals. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:906 / 911
页数:6
相关论文
共 35 条
[21]  
NEMETH I, 1989, BIOMED BIOCHIM ACTA, V48, pS53
[22]   Large neutral amino acids block phenylalanine transport into brain tissue in patients with phenylketonuria [J].
Pietz, J ;
Kreis, R ;
Rupp, A ;
Mayatepek, E ;
Rating, D ;
Boesch, C ;
Bremer, HJ .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (08) :1169-1178
[23]   Nutrition, physical growth, and bone density in treated phenylketonuria [J].
Przyrembel, H ;
Bremer, HJ .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (Suppl 2) :S129-S135
[24]   PLASMA SELENIUM LEVELS IN TREATED PHENYLKETONURIC PATIENTS [J].
ROTTOLI, A ;
LISTA, G ;
ZECCHINI, G ;
BUTTE, C ;
LONGHI, R .
JOURNAL OF INHERITED METABOLIC DISEASE, 1985, 8 :127-128
[25]   A heteroallelic mutant mouse model: A new orthologue for human hyperphenylalaninemia [J].
Sarkissian, CN ;
Boulais, DM ;
McDonald, JD ;
Scriver, CR .
MOLECULAR GENETICS AND METABOLISM, 2000, 69 (03) :188-194
[26]  
Scriver C.R., 1995, The Metabolic and Molecular Bases of Inherited Disease, V7th ed, P1015
[27]   Antioxidant status in hyperphenylalaninemia [J].
Sierra, C ;
Vilaseca, MA ;
Moyano, D ;
Brandi, N ;
Campistol, J ;
Lambruschini, N ;
Cambra, J ;
Deulofeu, R ;
Mira, A .
CLINICA CHIMICA ACTA, 1998, 276 (01) :1-9
[28]   Cerebral protein synthesis in a genetic mouse model of phenylketonuria [J].
Smith, CB ;
Kang, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (20) :11014-11019
[29]  
SMITH I, 1974, LANCET, V2, P540
[30]  
SRIVASTA.SK, 1969, J BIOL CHEM, V244, P9